Ra Medical Systems, Inc. (RMED) News
Filter RMED News Items
RMED News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
RMED News Highlights
- For RMED, its 30 day story count is now at 2.
- Over the past 7 days, the trend for RMED's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- VIEW are the most mentioned tickers in articles about RMED.
Latest RMED News From Around the Web
Below are the latest news stories about RA MEDICAL SYSTEMS INC that investors may wish to consider to help them evaluate RMED as an investment opportunity.
Ra Medical Systems Announces Milestone Achievement for Electrophysiology Division/ Ra Medical Systems, Inc. (NYSE American:RMED) announced today that VIVO, the lead product for the electrophysiology division, has been used in more than 1000 ventricular ablation procedures. VIVO, which stands for View Into Ventricular Onset, enables physicians to learn more about patient specific anatomy and better help them plan the ablation procedure. |
Ra Medical Systems Announces Proposed Name and Ticker Symbol ChangesRa Medical Systems, Inc. (NYSE American:RMED) today announced that its Board of Directors has approved changing the Company's corporate name to "Catheter Precision, Inc." The effective date of the name change is expected to be August 17, 2023. |
Ra Medical System’s Electrophysiology Division Has Increased Demand for its Non-invasive Mapping System/ Ra Medical Systems, Inc. (NYSE/American:RMED) announced today that there is an increase in clinical adoption by hospitals for its VIVO system. The three-dimensional non-invasive mapping system is one of the product lines within the company's electrophysiology division, Catheter Precision, LLC. |
RMED's LockeT Device Utilized in Structural Heart ProceduresRa Medical Systems, Inc. (RMED:NYSE/American) today announced that its new LockeT device, used as a suture retention device for percutaneous closures, has now been utilized in structural heart procedures. |
RMED’s Electrophysiology Division Expands International DistributionRa Medical Systems, Inc. (NYSE American:RMED) has announced that it has undertaken a strong effort to expand its distribution outside of the US. Last week RMED announced it has filed for the CE Mark on LockeT, its new device to assist in closure of percutaneous puncture sites. The effort to expand international distribution reflects the anticipated timing of the receipt of the LockeT CE Mark, which is expected during this third quarter. |
RMED's Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023Ra Medical Systems, Inc. (NYSE American:RMED) today announced that its Catheter Precision subsidiary has submitted to its European Notified Body the data necessary for determination of CE marking on its LockeT product. |
Ra Medical’s Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO SystemRa Medical Systems, Inc. (RMED:NYSE/American) announced today that its wholly owned subsidiary, Catheter Precision, Inc., has had its first customer, Heart Hospital of New Mexico at Lovelace Medical Center, complete 100 ventricular ablation procedures with the assistance of VIVO, a non-invasive 3D imaging system that identifies the earliest electrical activation of a ventricular arrhythmia. |
Ra Medical Systems Announces First Quarter ResultsRa Medical Systems, Inc. (NYSE American:RMED) today announced financial and company highlights for the first quarter ended March 31,2023. |
Ra Medical Systems Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-QRa Medical Systems, Inc. (the "Company") (NYSE American:RMED) announced today that on May 23, 2023, the Company received a notice from NYSE Regulation stating that the Company is not in compliance with the continued listing standards of the NYSE American (the "Exchange") under the timely filing criteria set forth in Section 1007 of the NYSE American Company Guide (the "Company Guide"). |
Ra Medical Systems Announces Delayed 10-Q FilingMay 22, 2023 / Ra Medical Systems, Inc. (RMED:NYSE/American) announced today that it will not file its Quarterly Report for the quarter ended March 31, 2023 within the filing deadline established by the Securities and Exchange Commission and will be a late filer with respect to such report. |